Showing results (111-120 of 154) with videos related to
Sort By:
Pageof 16
Journal of Immunological Methods|October 10, 1985
Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatographyW W Wong, R M Jack, J A Smith, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1991
The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complexR H Carter, D A Tuveson, D J Park, et al.The Journal of Experimental Medicine|March 1, 1988
Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteinsJ J Weis, L E Toothaker, J A Smith, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4bW W Wong, L B Klickstein, J A Smith, et al.The Journal of Clinical Investigation|July 1, 1985
Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosusJ G Wilson, R M Jack, W W Wong, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 geneJ G Wilson, W W Wong, E E Murphy, et al.The Journal of Clinical Investigation|January 1, 1981
Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertaseM D Kazatchkine, D T Fearon, D D Metcalfe, et al.Journal of Clinical Immunology|January 1, 1986
The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiationT F Tedder, J J Weis, L T Clement, et al.European Journal of Immunology|December 22, 1999
The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimerasA A Johnson, A Mirowski Rosengard, K Skjodt, et al.The Journal of Infectious Diseases|August 1, 1994
Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials NetworksD C Montefiori, B S Graham, J Y Zhou, et al.Pageof 16